TP53 and cancer: The E6 oncogene functions by inhibiting the p53 cancer suppressor pathway and blocking the RIG-I signaling pathway (immune escape mechanism), and the E7 oncogene suppresses retinoblastoma protein (Rb) and affects p21 and other pathways (31–33).